Drugs / Prosicca
last change Oct 2023 re-read 3 minutes ago

Prosicca

Developed for
dry eye syndrome
Investigated by
Medical University of Vienna

Trials 1

201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT02533154 Jul 2015 → Sep 2023 dry eye syndrome Medical University of Vienna Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Prosicca ClinicalTrials.gov intervention name — accepted as the source's own label NCT02533154 ↗
Route Topical “Route of administration: topical” NCT02533154 ↗